Bruker Corporation

Bruker Corporation

Develops analytical instruments for scientific research

Overview

Bruker Corporation provides analytical and diagnostic instruments used in life sciences, materials science, and environmental analysis. Its product lines include technologies such as nuclear magnetic resonance (NMR), mass spectrometry, imaging, and spectroscopy, which help researchers analyze the composition, structure, and properties of samples. These instruments work by measuring physical signals (like magnetic resonance, ion fragmentation patterns, or spectral fingerprints) from samples and translating them into data and insights via specialized software and workflows. Bruker differentiates itself through a long history of NMR expertise since 1960, a broad, integrated portfolio of measurement platforms, and a global footprint that supports researchers from development to routine analysis. Its goal is to empower scientists and industry professionals to advance research and solve real-world problems by providing reliable analytical tools and solutions.

Significant Headcount Growth

About Bruker Corporation

Simplify's Rating
Why Bruker Corporation is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

People at Bruker Corporation

People at Bruker Corporation who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Doubling $300M semiconductor metrology capacity by end-2026, driven by AI and new-fab demand.
  • Expecting three consecutive book-to-bill ratios above 1.0, signaling strong order momentum across key segments.
  • MyGenius PRO and rapid sepsis testing expand clinical diagnostics, with double-digit consumables growth into 2026.

What critics are saying

  • US academic funding cuts will sharply reduce NMR and mass spectrometry orders within 6–12 months.
  • Thermo Fisher and Agilent may displace GeoMx DSP and proteomics workflows by 9–15 months due to lower throughput.
  • China's 13%+ revenue exposure faces geopolitical decoupling and supply chain disruption risks by 12–18 months.

What makes Bruker Corporation unique

  • Bruker pioneered NMR technology since 1960 under Dr. Günther Laukien, establishing unmatched scientific heritage.
  • Distinct portfolio spans semiconductor metrology, infection diagnostics, and spatial biology with integrated multi-omics workflows.
  • Unique timsMRMS platform exceeds 10 million mass resolution for ultra-complex energy mixture analysis.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$622.5M

Above

Industry Average

Funded Over

2 Rounds

Post IPO Convertible funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Convertible Funding Comparison
Coming Soon

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Disability Insurance

Life Insurance

Dental Insurance

Flexible Work Hours

Employee Discounts

Stock Price

Growth & Insights

Headcount

6 month growth

14%

1 year growth

14%

2 year growth

14%

Recently Posted Jobs

Sign up to get curated job recommendations

Bruker Corporation is Hiring for 86 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →